ImmuCell Shares Rose Ahead of Holiday; Tuesday’s Open in Focus
ImmuCell shares were unchanged Monday with U.S. markets closed for Memorial Day. The stock ended Friday at $10.12, up 13.5% from a week earlier, after strong first-quarter results and a $2 million settlement from Norbrook. ImmuCell reported Q1 product sales of $10.4 million, up 28.4% year over year. The company’s next shareholder meeting is set for June 11.